Solution-mediated phase transformation of salts during dissolution: Investigation using haloperidol as a model drug

Journal of Pharmaceutical Sciences

Volumn 100, Issue 7, 2011, Pages 2755-2768

  Greco, Kristyn ^a   Mcnamara, Daniel P ^b   Bogner, Robin ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Penwest Pharmaceuticals   (United States)

Author keywords

Dissolution rate; Physicochemical properties; Preformulation; Raman spectroscopy; Solubility

Indexed keywords

BUFFER; HALOPERIDOL;

ARTICLE; DISSOLUTION; HYDRODYNAMICS; PH; RAMAN SPECTROMETRY;

EID: 79955590327     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22507     Document Type: Article

References (41)

1. Bahl D, Bogner RH. 2006. Amorphization of indomethacin by co-grinding with neusilin US2: Amorphization kinetics, physical stability and mechanism. Pharm Res 23(10):2317-2325.
2. Good DJ, Rodriguez-Hornedo N. 2009. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des 9(5):2252-2264.
3. Gu C-H, Young V, Jr., Grant DJW. 2001. Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation. J Pharm Sci 90(11):1878-1890.
4. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86(1):1-12.
5. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. 2010. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. J Pharm Sci 99(3):1254-1264.
6. Pudipeddi M, Serajuddin ATM. 2005. Trends in solubility of polymorphs. J Pharm Sci 94(5):929-939.
7. Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Deliv Rev 59(7):603-616.
8. Wermuth CG, Stahl PH., Eds. 2002. Handbook of pharmaceutical salts: Properties selection and use. Wiley-VCH, pp 1-7.
9. Law D, Schmitt EA, Marsh KC, Everitt EA, Wang W, Fort JJ, Krill SL, Qiu Y. 2004. Ritonavir-PEG 8000 amorphous solid dispersions: In vitro and in vivo evaluations. J Pharm Sci 93(3):563-570.
10. Li S, He H, Parthiban LJ, Yin H, Serajuddin ATM. 2005. IV-IVC considerations in the development of immediate-release oral dosage form. J Pharm Sci 94(7):1396-1417.
11. Engel GL, Farid NA, Faul MM, Richardson LA, Winneroski LL. 2000. Salt form selection and characterization of LY333531 mesylate monohydrate. Int J Pharm 198(2):239-247.
12. Shin BS, Kim CH, Jun YS, Yoon CH, Rho JI, Lee KC, Han HS, Yoo SD. 2004. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats. Drug Dev Ind Pharm 30(8):869-876.
13. Chen LR, Wesley JA, Bhattachar S, Ruiz B, Bahash K, Babu SR. 2003. Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm Res 20(5):797-801.
14. Rohrs BR, Thamann TJ, Gao P, Stelzer DJ, Bergren MS, Chao RS. 1999. Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharm Res 16(12):1850-1856.
15. Skultety PF. 1982. The effects of various carboxylic acids on the dissolution and solubility of triamterene. Iowa City: University of Iowa, pp 152-165.
16. Forbes RT, York P, Davidson JR. 1995. Dissolution kinetics and solubilities of p-aminosalicylic acid and its salts. Int J Pharm 126(1, 2):199-208.
17. Cardew PT, Davey RJ. 1985. The kinetics of solvent-mediated phase transformations. Proc Royal Soc London, Ser A: Math. Phys Eng Sci 398(1815):415-428.
18. Aaltonen J, Heinanen P, Peltonen L, Korteiarvi H, Tanninen VP, Christiansen L, Hirvonen J, Yliruusi J, Rantanen J. 2006. In situ measurement of solvent-mediated phase transformations during dissolution testing. J Pharm Sci 95(12):2730-2737.
19. Debnath S, Predecki P, Suryanarayanan R. 2004. Use of glancing angle X-Ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets. Pharm Res 21(1):149-159.
20. Murphy D, Rodriguez-Cintron F, Langevin B, Kelly RC, Rodriguez-Hornedo N. 2002. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm 246(1-2):121-134.
21. Rodriguez-Hornedo N, Lechuga-Ballesteros D, Wu HJ. 1992. Phase transition and heterogeneous/epitaxial nucleation of hydrated and anhydrous theophylline crystals. Int J Pharm 85(1-3):149-162.
22. Rodriguez-Hornedo N, Murphy D. 2004. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. J Pharm Sci 93(2):449-460.
23. Rodriguez-Hornedo N, Murphy D. 1999. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J Pharm Sci 88(7):651-660.
24. Paulekuhn GS, Dressman JB, Saal C. 2007. Trends in active pharmaceutical ingredient salt selection based on analysis of the orange book database. J Med Chem 50(26):6665-6672.
25. Janicki CA, Ko CY, Eds. 1980. Analytical profiles of drug substances. New York: Academic Press.
26. Li S, Doyle P, Metz S, Royce AE, Serajuddin ATM. 2005. Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug. J Pharm Sci 94(10):2224-2231.
27. Li S, Wong S, Sethia S, Almoazen H, Joshi YM, Serajuddin ATM. 2005. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH. Pharm Res 22(4):628-635.
28. Bogner RH, Bergman TL, Greco K, Michaels DJ, Chawarski SJ. 2008. Flow-through apparatus for microscopic investigation of dissolution of pharmaceutical solids. USA: (USA), U.S. Patent 2, 008, 013, 8261, June 12, 2008.
29. Greco K, Bergman TL, Bogner R. Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques. Pharmaceutical Development and Technology. 16(1):75-87.
30. Shah AC, Nelson KG. 1975. Evaluation of a convective diffusion drug dissolution rate model. J Pharm Sci 64(9):1518-1520.
31. Abrahamsson B, Pal A, Sjoeberg M, Carlsson M, Laurell E, Brasseur JG. 2005. A Novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm Res 22(8):1215-1226.
32. Pal A, Indireshkumar K, Schwizer W, Abrahamsson B, Fried M, Brasseur JG. 2004. Gastric flow and mixing studied using computer simulation. Proc Biol Sci 271(1557):2587-2594.
33. Bird RB, Stewart WE, Lightfoot EN. 2002. Transport Phenomena. 2nd ed. New York: John Wiley & Sons, pp 97-98.
34. Williams PT, Baker AJ. 1997. Numerical simulations of laminar flow over a 3D backward-facing step. Int J Numer Methods Fluids 24(11):1159-1183.
35. Levich VG. 1962. Physicochemical hydrodynamics. Prentice Hall: Upper Saddle River, New Jersey, pp 60-78.
36. Prasanna MD, Row TNG. 2001. Weak interactions involving organic fluorine: Analysis of structural motifs in flunarizine and haloperidol. J Mol Struct 562(1-3):55-61.
37. McNamara DP, Amidon GL. 1986. Dissolution of acidic and basic compounds from the rotating disk: Influence of convective diffusion and reaction. J Pharm Sci 75(9):858-868.
38. Mooney KG, Mintun MA, Himmelstein KJ, Stella VJ. 1981. Dissolution kinetics of carboxylic acids. I: Effect of pH under unbuffered conditions. J Pharm Sci 70(1):13-22.
39. Mooney KG, Mintun MA, Himmelstein KJ, Stella VJ. 1981. Dissolution kinetics of carboxylic acids. II: Effects of buffers. J Pharm Sci 70(1):22-32.
40. Tsinman K, Avdeef A, Tsinman O, Voloboy D. 2009. Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs. Pharm Res 26(9):2093-2100.
41. Pudipeddi M, Zannou EA, Vasanthavada M, Dontabhaktuni A, Royce AE, Joshi YM, Serajuddin ATM. 2008. Measurement of surface pH of pharmaceutical solids: A critical evaluation of indicator dye-sorption method and its comparison with slurry pH method. J Pharm Sci 97(5):1831-1842.